All In MedTech

Device Trial Radar · NCT05725187

Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation

Prospective Validation Study of Artificial Intelligence-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Sep 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

Oct 14, 2022

Primary completion

Dec 31, 2024

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Ewha Womans University Mokdong HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ewha Womans University Seoul Hospital
First posted
Feb 13, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 20 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to predict the occurrence of paroxysmal atrial fibrillation by finding high-risk group from normal sinus rhythm ECG through artificial intelligence-based prediction algorithm.

Conditions

  • Atrial Fibrillation Paroxysmal

Interventions

  • MobiCareDevice

    It is a 9.2g wearable electrocardiogram device, mobiCARE, in the form of a patch, and the model name is MC200M.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of paroxysmal AFTime frame: 1 week

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Yongin Severance Hospital

    Gyeonggi-do, South Korea

  • Gachon University Gil Medical Center

    Incheon, South Korea

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.